AceAge closes Series A financing round

AceAge-Logo-Wordmark-Tagline.png

AceAge, a healthcare technology company with its innovative medication dispenser, Karie, announced that it has closed a CA $5 million Series A financing round led by Longliv Ventures, with the participation of a fund managed by the Bloom Burton Investment Group. Karie allows users with complex medication regimes to take their medication independently. 

Learn more
Previous
Previous

Ripple Therapeutics secures Licensing Agreement and Series A Financing led by Théa Open Innovation

Next
Next

Molly Shoichet named one of the Top 100 Most Powerful Women in Canada